Cargando…
Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease
Rationale: Parkinson's disease (PD) is a prevalent neurodegenerative disorder that is characterized by degeneration of dopaminergic neurons (DA) at the substantia nigra pas compacta (SNpc). Cell therapy has been proposed as a potential treatment option for PD, with the aim of replenishing the l...
Autores principales: | Zheng, Xin, Han, Deqiang, Liu, Weihua, Wang, Xueyao, Pan, Na, Wang, Yuping, Chen, Zhiguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196819/ https://www.ncbi.nlm.nih.gov/pubmed/37215566 http://dx.doi.org/10.7150/thno.80271 |
Ejemplares similares
-
In depth characterization of midbrain organoids derived from wild type iPSC lines
por: Pavlinov, Ivan, et al.
Publicado: (2023) -
Human iPSC colon organoid function is improved by exposure to fecal fermentates
por: Pearce, Sarah C., et al.
Publicado: (2022) -
Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
por: Samata, Bumpei, et al.
Publicado: (2016) -
Merits and challenges of iPSC-derived organoids for clinical applications
por: Xu, Ziran, et al.
Publicado: (2023) -
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
por: Ma, Jie, et al.
Publicado: (2022)